EZH2 and central nervous system cancer: To test whether the inhibition of PD-L1 mediated by HOTAIR affects the immune sensitivity of tumor cells, we co-cultured glioma cells treated with EZH2 siRNA or HOTAIR siRNA with activated human peripheral blood mononuclear cells (PBMCs).